Back to Search
FRANK PRIMUS, M.D.
M.D.
Internal Medicine Physician
NPI: 1366734618IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A114110(CA)
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2008
Research & Publications (17)
Argon beam coagulation as an adjuvant for local control of giant cell tumor.
PMID 16957652·Clin Orthop Relat Res·2007
8-other
BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury.
PMID 17545436·J Bone Joint Surg Am·2007
7-preclinical
Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
PMID 17096339·Int J Cancer·2007
7-preclinical
CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
PMID 16044253·Cancer Immunol Immunother·2006
7-preclinical
Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.
PMID 17020947·J Virol·2006
4-observational
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2.
PMID 15930316·Cancer Res·2005
7-preclinical
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
PMID 16040807·Proc Natl Acad Sci U S A·2005
7-preclinical
A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines.
PMID 15199414·J Clin Invest·2004
7-preclinical
Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
PMID 15256474·Cancer Res·2004
7-preclinical
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.
PMID 12916958·Cancer Immun·2003
7-preclinical
Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
PMID 12782590·Cancer Res·2003
7-preclinical
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice.
PMID 11672905·Vaccine·2001
7-preclinical
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.
PMID 11591784·J Immunol·2001
7-preclinical
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.
PMID 11300483·Clin Cancer Res·2001
7-preclinical
Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
PMID 10969795·Cancer Res·2000
7-preclinical
Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen.
PMID 10946810·Cancer Immunol Immunother·2000
7-preclinical
Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
PMID 10709090·Int J Cancer·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 109 S LAKE MERCED HLS APT 3B
SAN FRANCISCO, CA 94132 - Phone
- (773) 456-3316
Quick Facts
- NPI
- 1366734618
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 17
Are you this provider?
Claim Your Profile